Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
van Ham NCM, Glazemakers S, van der Ende-van Loon M, Nieuwenhuijzen GAP, Rutten HJT, Tolenaar JL, Jacobs A, Burger JWA, Ketelaers SHJ, Bloemen JG. van Ham NCM, et al. Among authors: nieuwenhuijzen gap. Eur J Surg Oncol. 2024 Mar 19;50(6):108259. doi: 10.1016/j.ejso.2024.108259. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 38552415
Treatment of locally advanced rectal cancer.
Klaassen RA, Nieuwenhuijzen GA, Martijn H, Rutten HJ, Hospers GA, Wiggers T. Klaassen RA, et al. Surg Oncol. 2004 Aug-Nov;13(2-3):137-47. doi: 10.1016/j.suronc.2004.08.004. Surg Oncol. 2004. PMID: 15572096 Review.
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.
Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, van den Brule AJ, van den Berg HA, Rutten HJ. Dresen RC, et al. Ann Surg Oncol. 2008 Jul;15(7):1937-47. doi: 10.1245/s10434-008-9896-z. Epub 2008 Apr 4. Ann Surg Oncol. 2008. PMID: 18389321 Free PMC article.
T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.
Martijnse IS, Dudink RL, Kusters M, Vermeer TA, West NP, Nieuwenhuijzen GA, van Lijnschoten I, Martijn H, Creemers GJ, Lemmens VE, van de Velde CJ, Sebag-Montefiore D, Glynne-Jones R, Quirke P, Rutten HJ. Martijnse IS, et al. Ann Surg Oncol. 2012 Feb;19(2):392-401. doi: 10.1245/s10434-011-1955-1. Epub 2011 Jul 27. Ann Surg Oncol. 2012. PMID: 21792506 Clinical Trial.
314 results